"We believe that reducing genital herpes symptoms is important. Therefore, we recommend Gene-Eden-VIR, which was proven to reduce genital herpes symptoms in a post-marketing clinical study that followed FDA guidelines." – Mike Evans, polyDNA
Rochester, NY (PRWEB) February 08, 2014
Studies show that women with genital herpes (HSV-2) suffer more from bacterial vaginosis (BV) (1). When a woman has BV, “the normal balance of bacteria in the vagina is disrupted and replaced by an overgrowth of certain bacteria. It is sometimes accompanied by discharge, odor, pain, itching, or burning.” (See the CDC’s webpage on BV, last updated September 1, 2010)(2). The study shows that genital herpes increases the risk of acquiring BV by 30% (1). Thus, polyDNA recommends that women with a genital herpes (HSV-2) infection consider Gene-Eden-VIR to help the immune system target the latent herpes virus.
“BV is associated with an imbalance in the bacteria that are normally found in a woman's vagina. The vagina normally contains mostly "good" bacteria, and fewer "harmful" bacteria. BV develops when there is an increase in harmful bacteria (2).” A genital herpes infection may change the balance between the good and harmful bacteria. “HSV-2 reactivation may lead to immune activation in the genital mucosa, altering the vaginal microbiota (1).”
A genital herpes infection makes it more likely to acquire BV. The same is true in reverse. That is, bacterial vaginosis makes it more likely to acquire herpes and HIV. BV can also make it easier to transfer genital herpes to a sexual partner. “The increased likelihood of BV following HSV-2 infection could serve as a mechanism for enhancing further herpes transmission because BV increases genital shedding of HSV-2. In addition, both HSV-2 and BV have been associated with a greater risk of acquiring and transmitting HIV-1 (1).”
“We believe that reducing genital herpes symptoms is important. Therefore, we recommend Gene-Eden-VIR, which was proven to reduce genital herpes symptoms in a post-marketing clinical study that followed FDA guidelines.” – Mike Evans, polyDNA
Women infected with the latent HSV-2 can ask their doctors about Gene-Eden-VIR, or they can go online to learn more. Gene-Eden-VIR is a safe, natural product that was proven to reduce genital herpes symptoms in a clinical study published in the peer reviewed, medical journal Pharmacology & Pharmacy, in a special edition on Advances in Antiviral Drugs on August 12, 2013.
The study showed that Gene-Eden-VIR reduced genital herpes symptoms and was safe and effective (3). “Up to 70% of those studied reported a decrease in HSV-2 symptoms (3).”
Each ingredient of Gene-Eden-VIR was chosen through a scientific approach. Scientists scanned thousands of scientific and medical papers published in various medical and scientific journals around the world to identify the safest, most effective natural ingredients that target the latent form of genital herpes (3).
To learn more about Gene-Eden-VIR and HPV, visit http://gene-eden-kill-virus.com/Herpes-Remedy.php. All orders of Gene-Eden-VIR are completely confidential, and no information is shared or sold to any third party. Privacy is assured.
(1) Incident Herpes Simplex Virus Type 2 Infection Increases the Risk of Subsequent Episodes of Bacterial Vaginosis. Published on December 13, 2013.
(2) CDC - Sexually Transmitted Diseases (STDs) - Bacterial Vaginosis - CDC Fact Sheet. Last updated on September 1, 2010.
(3) Gene-Eden-VIR Is Antiviral: Results of a Post Marketing Clinical Study. Published on August 12, 2013.
polyDNA is a biotechnology company that develops dietary supplements using the unique scientific method developed by Dr. Hanan Polansky, which is based on Computer Intuition.
In addition to his unique scientific method, Dr. Polansky published the highly acclaimed scientific discovery, called Microcompetition with Foreign DNA. The discovery explains how foreign DNA fragments, and specifically, DNA of latent viruses, cause most major diseases.
polyDNA developed Gene-Eden-VIR , an antiviral natural remedy that helps the immune system kill latent viruses.